Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market

Aug.16.2024
Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
Fake ZYN nicotine pouches flood the US market, posing serious risks to consumers and prompting concerns about brand integrity.

Special announcement:

Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
The whistleblower claimed that they have never found a genuine box of ZYN in the four states they visited.


The information in this article comes from online users, and FIRSTS is unable to verify the authenticity of this information. We are simply providing industry news and information quickly and widely.

Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
An American wholesaler consulted the informant in this article about the source of ZYN products. | Image source: Informant


If you have any objections to the revelations in this article or would like to communicate with us, please feel free to contact us through the following email address: info@2firsts.com.

Rampant Counterfeit ZYN Nicotine Pouches in U.S. Market
Click on the image to read "The Mystery of Counterfeit Nicotine Pouches: Why are Fake Products Proliferating? How to Combat Counterfeit Goods Displacing Genuine Ones?


This article is not responsible for the accuracy of the information disclosed. Readers should maintain a rational mindset while reading and carefully evaluate the information.


In the highly competitive and saturated e-cigarette market, nicotine pouches are gaining attention as an emerging area. However, due to technology patents protection, technological barriers, and regulatory policy uncertainty, the market for nicotine pouches is flooded with counterfeit products. Addressing this issue, 2FIRSTS conducted a thorough analysis in their previous report, "Suspicions of Counterfeiting in the Nicotine Pouch Industry: Why are Fake Products So Common? How to Address the Problem of Bad Money Driving Out Good Money?" The report revealed the risks of counterfeit and compliance in the rapidly growing nicotine pouch market, highlighting the complexities of the market.


After the article was published, a senior figure in the nicotine pouch industry who is currently visiting the US market shared his observations with 2FIRSTS. According to him, counterfeit versions of the well-known brand ZYN are rampant in New York, New Jersey, Virginia, and Arizona. He described the situation as alarming, stating that during his visits he did not come across a single authentic box of ZYN in any of these four states.


Counterfeit ZYN products are now being sold in several states in the United States at twice the price of VELO.


According to reports, in the American market, in addition to the ZYN brand, there are also other nicotine pouch brands such as ROGUE, VELO, ON!, and FRE. However, ZYN is not only the most widely available brand, but also the most rampant in terms of counterfeit products.


ZYN, acquired by Philip Morris International (PMI) from Swedish Match, saw its shipment volume of nicotine pouches reach 266.7 million cans in the first half of 2024, representing a 63.5% year-on-year increase, as indicated in its performance report.


The sharp increase in sales has led to a market imbalance of supply and demand. According to industry insiders, counterfeit ZYN products are widely distributed in various retail terminals such as convenience stores, tobacco shops, e-cigarette stores, and gas stations, with prices ranging from $6.99 to $9.99, similar to authentic products. However, the nicotine pouch brand VELO, owned by British American Tobacco, is priced at only $4.99, while FRE is priced at just $2.99.


The appearance is so real that it is difficult to distinguish, and the taste is described as "sugar-like.


What is even more worrying is that these counterfeits closely resemble the authentic products in terms of appearance, including box design, color combinations, and material textures, making it almost impossible to distinguish between the two. As a result, not only do average consumers struggle to identify the authenticity of products, but even most shop owners lack a clear understanding of the authenticity of the goods they sell.


Although distinguishing between real and fake ZYN can be difficult, industry insiders have provided a viable method. They point out that the bottom of the box of ZYN contains a QR code, which consumers can scan after purchasing the genuine product to directly access the official ZYN website. If the QR code scanned is for a counterfeit product, it will first redirect to an unknown website before potentially redirecting to the ZYN official website.


In addition, authenticity can also be discerned through the use of experience. According to him, counterfeit ZYN products have significant differences in user experience compared to the genuine ones, with the fakes giving a feeling "like candy." He speculated that these imitation products may not contain any nicotine at all, or only contain a small amount of nicotine, in order to reduce production costs.


Where do counterfeit products come from?


In the article "Suspicions of Nicotine Pouch Counterfeiting: Why are Fake Products Frequently Emerging? How to Combat Bad Money Drives Out Good Money?" 2FIRSTS once held in-depth discussions with industry experts on this issue. At that time, several industry insiders pointed out that China is one of the sources of counterfeit nicotine pouches.


According to the investigation conducted by the aforementioned sources, the conclusion is unanimous - the majority of counterfeit ZYN products originate from manufacturers in China. Some American wholesalers even inquired about the supply chain for ZYN pouches and bluntly stated, "Everyone making zyn in china now.


However, it is understood that ZYN's official production facility is located in Sweden. Philip Morris International (PMI) announced in July of this year that a new ZYN production plant will be built in Colorado, USA. Currently, there are no officially authorized contract factories in China.


This phenomenon has already raised concerns among some industry insiders in the United States, who worry that as brands continue to expand, the issue of counterfeit goods may also arise. As mentioned by the aforementioned individuals, a client who has already obtained PMTA certification raised the question to him: if they were to manufacture products in China, would they also face the risk of being counterfeited as their business grows.


An expert in the emerging tobacco industry stated that from an industry perspective, nicotine pouches as a new form of nicotine consumption have always been controversial, especially in terms of their use by young people and health impacts. The issue of counterfeit products may exacerbate these concerns, prompting regulatory agencies and public health experts to more closely scrutinize this market.


At the same time, for legitimate manufacturers, the proliferation of counterfeit goods could damage their brand image and force them to invest more resources to protect their intellectual property and consumer rights.


For industries in China, this approach will lead to a severe lack of trust in Chinese-made nicotine pouch products overseas, causing incalculable damage to the industry's progress and development.


2FIRSTS will continue to monitor the counterfeit nicotine pouch incident and provide timely updates on the latest developments.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia Liquid Nicotine Returns to Poisons List, Leaving Vape Retail and RM354 Million Tax Collection in Legal Uncertainty
Malaysia’s withdrawal of its appeal in a landmark liquid-nicotine case has left a High Court ruling that struck down the 2023 nicotine exemption in force, bringing liquid and gel nicotine used in vaping products back under the Poisons Act 1952. At the same time, the Control of Smoking Products for Public Health Act 2024 continues to provide a regulatory framework for vaping products, creating uncertainty over retail sales, taxation and existing inventory. MPs are calling for nicotine vape sales and excise collection to stop, including refunds of more than RM354 million collected since 2023, while industry and consumer groups are asking the government to clarify the current legal position.
Sep.04
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s state of Victoria has activated new powers allowing Tobacco Licensing Victoria and police to shut premises suspected of selling, supplying or possessing illicit tobacco for up to 90 days. Longer closures can be ordered by a magistrates’ court. Businesses subject to closure orders must generally cease all trading and will be placed on a public list. Breaching a closure order can carry penalties of up to A$2.5 million and 20 years in prison.
Sep.10
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28